Cancer
eBook - ePub

Cancer

Oxidative Stress and Dietary Antioxidants

  1. 308 pages
  2. English
  3. ePUB (mobile friendly)
  4. Available on iOS & Android
eBook - ePub

Cancer

Oxidative Stress and Dietary Antioxidants

Book details
Book preview
Table of contents
Citations

About This Book

Cancer: Oxidative Stress and Dietary Antioxidants bridges the trans-disciplinary divide and covers in a single volume the science of oxidative stress in cancer and then the potentially therapeutic usage of natural antioxidants in the diet or food matrix. The processes within the science of oxidative stress are described in concert with other processes such as apoptosis, cell signaling, and receptor mediated responses. This approach recognizes that diseases are often multifactorial and that oxidative stress is a single component of this.

Oncologists, cancer researchers, and nutritionists are separated by divergent skills and professional disciplines that need to be bridged in order to advance preventative as well as treatment strategies. While oncologists and cancer researchers may study the underlying pathogenesis of cancer, they are less likely to be conversant in the science of nutrition and dietetics. On the other hand, nutritionists and dietitians are less conversant with the detailed clinical background and science of oncology. This book addresses this gap and brings each of these disciplines to bear on the processes inherent in the oxidative stress of cancer.

  • Nutritionists can apply information related to mitochondrial oxidative stress in one disease to diet-related strategies in another unrelated disease
  • Dietitians can prescribe new foods or diets containing anti-oxidants for conditions resistant to conventional pharmacological treatments
  • Dietitians, after learning about the basic biology of oxidative stress, will be able to suggest new treatments to their multidisciplinary teams
  • Nutritionists and dietitians will gain an understanding of cell signaling, and be able to suggest new preventative or therapeutic strategies with anti-oxidant rich foods

Frequently asked questions

Simply head over to the account section in settings and click on “Cancel Subscription” - it’s as simple as that. After you cancel, your membership will stay active for the remainder of the time you’ve paid for. Learn more here.
At the moment all of our mobile-responsive ePub books are available to download via the app. Most of our PDFs are also available to download and we're working on making the final remaining ones downloadable now. Learn more here.
Both plans give you full access to the library and all of Perlego’s features. The only differences are the price and subscription period: With the annual plan you’ll save around 30% compared to 12 months on the monthly plan.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes, you can access Cancer by Victor R Preedy in PDF and/or ePUB format, as well as other popular books in Medicine & Oncology. We have over one million books available in our catalogue for you to explore.

Information

Year
2014
ISBN
9780124055247
Subtopic
Oncology
Section 1
Oxidative Stress and Cancer
Outline
Chapter 1. The Role of Oxidative Stress in Breast Cancer
Chapter 2. Oxidative Stress and Prostate Cancer
Chapter 3. Oxidative Stress in Lung Cancer
Chapter 4. Oxidative Stress and Stomach Cancer
Chapter 5. The Role of Oxidative Stress in Ovarian Cancer
Chapter 6. Role of Oxidative Stress in Human Papillomavirus-Driven Cervical Carcinogenesis
Chapter 7. Inflammation and Oxidative DNA Damage
Chapter 1

The Role of Oxidative Stress in Breast Cancer

Gayathri R. Devi, Jennifer L. Allensworth, Myron K. Evans, and Scott J. Sauer Department of Surgery, Division of Surgical Sciences and Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA

Abstract

Breast cancer is the most common cancer in women worldwide and it accounts for the second highest morbidity and mortality. Disease etiology and progression is multifactorial and several risk factors associated with breast cancer exert their effects by modulation of oxidative stress status in the cells. Oxidative stress occurs due to an imbalance between reactive species and antioxidant defenses in the cells. Excess reactive species are deleterious in normal cells, while in cancer cells, they can lead to accelerated growth and survival correlating with an aggressive and therapy-resistant phenotype. Specifically, risk factors and their effect on the oxidative stress response are associated with breast cancer development, progression, and treatment outcome.
This chapter provides a review of the accepted concepts, recent findings, and limitations in the understanding of the cross-talk between antioxidant capacity, redox-sensitive transcription factors, and cell survival/death signaling in oxidative stress response and redox adaptation in breast cancer. Addressing these matters and identifying pathway dysregulation is required for a rational basis to improve the design of redox-related therapeutics and clinical trials in breast cancer.

Keywords

reactive oxygen species; redox adaptation; antioxidants; superoxide dismutase; apoptosis; estrogen; epigenetics; inflammation; aging; hypoxia
List of Abbreviations
8-OHdG 8-Hydroxydeoxyguanosine
γ-GCL Gamma-glutamylcysteine synthetase
γ-GCS Gamma-glutathione synthase
Akt Protein kinase B
AP-1 Activator protein-1
ARE Antioxidant response element
Bax Bcl-2-associated X protein
Bcl-2 B-cell lymphoma 2
Bcl-xl B-cell lymphoma-extra large
BRCA1 Breast cancer susceptibility gene 1
BSO Buthionine sulfoximine
CA9 Carbonic anhydrase IX
c-Abl Abelson murine leukemia viral oncogene homolog
CD Conjugated dienes
cFLIP Cellular FLICE inhibitory protein
cIAP Cellular inhibitor of apoptosis
COX2 Cyclo-oxygenase 2
CYP Cytochrome P450
CYP1B1 CYP family 1, subfamily B, polypeptide 1
CYP1A1/2 CYP family 1, subfamily A, polypeptide 1/2
DNMT DNA methyltranserase
EGFR Epidermal growth factor receptor
eNOS Endothelial nitric oxide synthases
EPO Erythropoietin
ER Estrogen receptor
ERE Estrogen response elements
ERK Extracellular-signal-regulated kinase
GLUT1 Glucose transporter 1
GPCR G-protein coupled receptor
GPx Glutathione peroxidase
GSH Glutathione
GSK3β Glycogen synthase kinase 3β
GSR Glutathione reductase
GSS Glutathione synthetase
GSSG Glutathione disulfide
GST Glutathioine S-transferase
GSTP Glutathione-S-transferase P1
HDAC1 Histone deacetylase 1
HER2 Human epidermal growth factor receptor 2
HIF-1 Hypoxia inducible factor 1
HO-1 Heme oxygenase 1
HRE Hypoxia response elements
IGFBP5 Insulin-like growth factor-binding protein 5
IHC Immunohistochemistry
IKK IκB Kinase
IL-6 Interleukin-6
iNOS Inducible nitric oxide synthases
Keap1 Kelch-like ECH-associated protein 1
LDH-A Lactate dehydrogenase-A
LOH Loss of heterozygosity
LOOH Lipid hydroperoxides
MAPK Mitogen-activated protein kinase
MAPKKK MAPK kinase kinase
MDA Malondialdehyde
MMP Matrix metalloproteinase
mETC Mitochondrial electron transport chain
NDRG1 N-Myc downstream-regulated 1
NF-κB Nuclear factor kappa-light-chain-enhancer of activated B cells
nNOS Neuronal nitric oxide synthases
NOS Nitric oxide synthases
NQO1 NADH quinone oxidoreductase 1
Nrf2 Nuclear factor (erythroid-derived 2)-like 2
NSAID Nonsteroidal anti-inflammatory drug
PGE2 Prostaglandin 2
PI3K Phosphatidylinositide 3-kinase
PR Progesterone receptor
Prx Peroxiredoxins
PTEN Phosphatase and tensin homolog
Ras Rat sarcoma protein
RNS Reactive nitrogen species
ROS Reactive oxygen species
RTK Receptor tyrosine kinase
SERM Selective estrogen receptor modulator
siRNA Small interfering RNA
Smac(Diablo) Second mitochondria-derived activator of caspases
SOD Superoxide dismutase
Src Sarcoma protein
TAK1 Transforming growth factor-β activated kinase-1
tBHQ tert-Butylhydroquinone
TERT Telomerase reverse transcriptase protein
TNBC Triple negative breast cancer
TNFα Tumor necrosis factor α
TRAF TNF receptor associated factor
TRAIL TNF-related apoptosis-inducing ligand
Trx Thioredoxins
VEGF Vascular endothelial growth factor
XIAP X-linked inhibitor of apoptosis protein

Introduction

Redox Homeostasis: ROS Production and Elimination

Reactive species, also termed oxidants, are byproducts of key aerobic cellular processes of respiration, metabolism, and the mitochondrial electron transport chain (mETC),1,2 and are removed continuously by an array of antioxidant mechanisms. These species include reactive oxygen species (ROS) and reactive nitrogen species (RNS). ROS are mainly comprised of neutral molecules (H2O2), radicals (hydroxyl radicals), and ions (superoxide).3 On the other hand, nitric oxide, the main form of RNS in the cell, is produced by a family of enzymes (nitric oxide synthases, NOSs) that include iNOS (inducible), eNOS (endothelial), and nNOS (neuronal).4 ROS can also be produced at somewhat low levels in response to the activation of certain signaling pathways, such as the epidermal growth factor receptor (EGFR) pathway.5 Activation of these pathways has been shown to be important for proliferation, as well as the oncogenic and metastatic potential of cancer cells. Extracellular sources of ROS include tobacco, smoke, drugs, xenobiotics, radiation, and high levels of heat, most of which either activate a stress response or directly damage cellular components leading to ROS production.6
Cells have natural...

Table of contents

  1. Cover image
  2. Title page
  3. Table of Contents
  4. Copyright
  5. Preface
  6. List of Contributors
  7. Section 1 Oxidative Stress and Cancer
  8. Section 2 Antioxidants and Cancer
  9. Index
  10. Color Plates